GNIIF Comptes : Analyse IA GNI Group Ltd

Accueil

Stock

GNIIF

Comptes financiers

GNIIF Financier

GNI Group Ltd

$15.5

À la fermeture : Apr 06, 16:00:00 GMT-4

$15.5

Post-Marché: Apr 06, 19:23:44 GMT-4

Aperçu Prévision Gagner Dividendes Comptes financiers

Revenus

État de situation

Flux de trésorerie

Annuel

Trimestriellement

GNIIF Revenu

Chiffres en millions de dollars américains. L'exercice financier va de février à janvier.

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenus	26,840	26,840	23,611	26,010	17,418	12,690
Croissance des revenus (H/H)	14%	14%	-9%	49%	37%	30%
Coût des ventes	6,847	6,847	5,574	3,579	2,674	1,600
Bénéfice brut	19,993	19,993	18,037	22,431	14,744	11,089
Vente, Général et Administration	19,002	19,002	15,771	14,620	10,965	7,958
Recherche et développement	3,298	3,298	2,811	2,557	2,545	2,015
Frais d'exploitation	23,476	23,476	16,476	17,252	13,573	10,060
Autres revenus (charges) non opérationnels	0	--	59	52	12	37
Bénéfice avant impôts	-4,646	-4,646	238	12,612	767	1,107
Charge d'impôt sur le revenu	2,671	2,671	247	3,108	1,636	1,051
Bénéfice net	-4,411	-4,411	1,098	8,094	388	1,066
Croissance du bénéfice net	-501.99%	-501.99%	-86%	1,986%	-64%	-15%
Actions en circulation (diluées)	55.66	52.46	50	48.89	47.93	48.29
Variation des actions (H-H)	11%	5%	2%	2%	-1%	8%
EPS (dilué)	-79.23	-84.07	21.96	165.55	8.11	22.07
Croissance du EPS	-462%	-483%	-87%	1,941%	-63%	-21%
Flux de trésorerie libre	-3,966	-3,966	-4,701	4,473	-1,546	-142
Flux de trésorerie libre par action	--	--	--	--	--	--
Marge brute	74.48%	74.48%	76.39%	86.23%	84.64%	87.38%
Marge opérationnelle	-12.97%	-12.97%	6.6%	19.9%	6.71%	8.1%
Marge bénéficiaire	-16.43%	-16.43%	4.65%	31.11%	2.22%	8.4%
Marge du flux de trésorerie libre	-14.77%	-14.77%	-19.91%	17.19%	-8.87%	-1.11%
EBITDA	-2,346	-2,346	2,543	5,786	1,691	1,412
Marge EBITDA	-8.74%	-8.74%	10.77%	22.24%	9.7%	11.12%
D&A pour le résultat opérationnel	1,137	1,137	983	608	521	383
EBIT	-3,483	-3,483	1,560	5,178	1,170	1,029
Marge EBIT	-12.97%	-12.97%	6.6%	19.9%	6.71%	8.1%
Taux d'imposition effectif	-57.49%	-57.49%	103.78%	24.64%	213.29%	94.94%

Statistiques clés

Clôture préc.

$15.5

Prix d'ouverture

$15.5

Plage de la journée

$15.5 - $15.5

Plage de 52 semaines

$12.02 - $19.1

Volume

100

Volume moyen

Rendement en dividend

BPA (TTM)

-0.02

Capitalisation boursière

$863.1M

Qu’est-ce que GNI GROUP LTD ?

GNI Group Ltd. engages in the development, research, manufacture, and sale of pharmaceutical drugs and traditional Chinese medicines. The company is headquartered in Chuo-Ku, Tokyo-To. The company went IPO on 2007-08-31. The firm conducts global pharmaceutical research and development, manufacturing and distribution and biomaterials business. The firm operates in two business segments. The Pharmaceuticals segment conducts research and development, manufacturing, and sale of developed compounds, including ETUARY sold in the China market and Hydronidone (F351), which is in clinical trials. The main products also include other pharmaceuticals and reagents. The Medical Devices segment develops, manufactures, and sells medical devices such as biomaterials in the United States. This segment also includes medical device Designated Marketing Authorization Holder (DMAH) and In-Country Caretaker (ICC) services. The firm also conducts clinical and business development in the United States and conducts clinical development of F351 for Metabolic Dysfunction-Associated Steatohepatitis in the United States.



Fonctionnalités

Copilote IA pour actions et cryptomonnaies

Prédiction des prix

Suivi des collectes de fonds

Thèmes

Comparaison de cryptomonnaies

Ressources